These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23278587)

  • 41. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.
    Hong Y; Skeie GO; Zisimopoulou P; Karagiorgou K; Tzartos SJ; Gao X; Yue YX; Romi F; Zhang X; Li HF; Gilhus NE
    J Neurol; 2017 May; 264(5):955-962. PubMed ID: 28364296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The auto-antigen repertoire in myasthenia gravis.
    Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
    Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Fujinami A; Ohta M
    Neurology; 2005 Dec; 65(12):1988. PubMed ID: 16380629
    [No Abstract]   [Full Text] [Related]  

  • 45. Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Double Seronegative Myasthenia Gravis: A Systematic Review.
    Bacchi S; Kramer P; Chalk C
    Can J Neurol Sci; 2018 Jan; 45(1):62-67. PubMed ID: 29334041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic and clinical classification of autoimmune myasthenia gravis.
    Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
    J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
    Benveniste O; Jacobson L; Farrugia ME; Clover L; Vincent A
    J Neuroimmunol; 2005 Dec; 170(1-2):41-8. PubMed ID: 16213598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Familial autoimmune MuSK positive myasthenia gravis.
    Corda D; Deiana GA; Mulargia M; Pirastru MI; Serra M; Piluzza MG; Carcassi C; Sechi G
    J Neurol; 2011 Aug; 258(8):1559-60. PubMed ID: 21369718
    [No Abstract]   [Full Text] [Related]  

  • 49. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AChR-and MuSK-positive myasthenia gravis: Double trouble.
    Zouvelou V; Psimenou E
    J Neuroimmunol; 2020 Nov; 348():577364. PubMed ID: 32916523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
    Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
    Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
    Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis.
    Trakas N; Zisimopoulou P; Tzartos SJ
    J Neuroimmunol; 2011 Dec; 240-241():79-86. PubMed ID: 21993075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.
    Cordts I; Bodart N; Hartmann K; Karagiorgou K; Tzartos JS; Mei L; Reimann J; Van Damme P; Rivner MH; Vigneron A; Weis J; Schulz JB; Tzartos SJ; Claeys KG
    J Neurol; 2017 Jun; 264(6):1193-1203. PubMed ID: 28516329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.
    Stergiou C; Lazaridis K; Zouvelou V; Tzartos J; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Gilhus NE; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Bogomolovas J; Labeit D; Labeit S; Tzartos SJ
    J Neuroimmunol; 2016 Mar; 292():108-15. PubMed ID: 26943968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.
    Stein B; Bird SJ
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):163-4. PubMed ID: 21321497
    [No Abstract]   [Full Text] [Related]  

  • 58. A Patient with Fulminant Myasthenia Gravis Is Seropositive for Both AChR and LRP4 Antibodies, Complicated by Autoimmune Polyglandular Syndrome Type 3.
    Inoue H; Yamada K; Fujii A; Tomonari T; Mizuno K; Mita K; Higuchi O; Akao M; Matsukawa N
    Intern Med; 2020 Sep; 59(17):2177-2181. PubMed ID: 32461531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.